Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedVersion update from v3.0.2 to v3.2.0 indicating a new release; no other content changes detected.SummaryDifference0.1%
- Check16 days agoChange DetectedUpdates the revision tag from v3.0.2 to v3.1.0, indicating a new release version without substantive changes to visible content.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows revision v3.0.2, indicating a new release. The 'Back to Top' link was removed; aside from the version bump, there are no other substantive changes to pricing, stock, or time-related information.SummaryDifference0.3%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has updated its facility name and location details, specifically clarifying the location to South Korea, Gyeonggi-do, Seongnam-si, while removing previous location terms and references to vaccines.SummaryDifference2%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.